Login / Signup

Survey to inform trial of low-titer group O whole-blood compared to conventional blood components for children with severe traumatic bleeding.

Julia H KolodziejJulie C LeonardCassandra D JosephsonBarbara A GainesStephen R WisniewskiMark H YazerPhilip C Spinella
Published in: Transfusion (2021)
A majority of respondents supported an RCT comparing LTOWB to component therapy in children with severe traumatic bleeding.
Keyphrases
  • spinal cord injury
  • young adults
  • atrial fibrillation
  • early onset
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase iii
  • phase ii
  • mesenchymal stem cells
  • cell therapy
  • double blind
  • placebo controlled